Omeros (OMER): OMS721 For Kidney Diseases Looks Exciting - Wedbush

October 18, 2016 8:56 AM EDT Send to a Friend
Wedbush analyst, Liana Moussatos, reiterated her Outperform rating on shares of Omeros Corp. (NASDAQ: OMER) after initial results for OMS721 ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login